|
|
Oncology Formulations
KLab is one of the
pioneers in India in manufacturing oncology
formulations. KLab has one of the largest ranges of
oncology formulations. KLab has a WHO GMP approved
facility. KLab manufactures tablets, capsules,
powder and liquid injectables. KLab has a dedicated
lyophiliser for various oncology products. KLab is
currently registering its products in more than 30
countries in Africa, Latin America, CIS and
South-East Asia. KLab has reached strategic tie-ups
to supply various products on a turnkey basis with
brand names, marketing strategies, promotional
material as required by the overseas pharmaceutical
companies. KLab has a dedicated field force of 24
persons covering most of the oncologists and
oncology institutions in India. KLab is already
supplying finished formulations to large number of
Indian companies on contract basis.
|
| BICALUTAMIDE
TAB |
HYDROXYUREA CAPS |
| BLEOMYCIN INJ |
IFOSFAMIDE FOR INJ |
| CARBOPLATIN
INJ |
IMATINIB MESYLATE CAPS |
| CISPLATIN INJ |
IRINOTECAN HCL INJ |
|
CYCLOPHOSPHAMIDE FOR INJ |
LIPOSOMAL AMPHOTERICIN HCL
INJ |
| DOXORUBICIN
INJ |
METHOTREXATE TAB |
| EPIRUBICIN
HCL INJ |
PACLITAXEL INJ |
| ETOPOSIDE
CAPS |
TAMOXIFEN CITRATE TAB |
| FLUROURACIL
INJ |
VINCRISTINE SULPHATE INJ |
| GEMCITABINE
HCL FOR INJ |
|
|
|
Present
|
 |
|
Introduced Patented Products based on
NDDS
(Marketed in India and out-Licensed for the
Developing Countries)
|
| |
|
Future
|
 |
|
Patents driven
by NDDS, Nano and Dendrimers
(To be marketed in India and to be out Licensed to
the developed countries)
|
| |
|
